Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 569

1.

Stroke-like Migraine Attacks after Radiation Therapy (SMART) Syndrome Followed by Cerebral Infarction.

Takahashi H, Kimura T, Yuki N, Yoshioka A.

Intern Med. 2018 Jul 1;57(13):1921-1924. doi: 10.2169/internalmedicine.9579-17. Epub 2018 Feb 28.

2.

Peripheral neuropathies: Subcutaneous immunoglobulin - the future of CIDP treatment?

Wakerley BR, Yuki N.

Nat Rev Neurol. 2018 Mar;14(3):130-131. doi: 10.1038/nrneurol.2017.179. Epub 2018 Jan 12. No abstract available.

PMID:
29326423
3.

Down-regulation of glutamate release from hippocampal neurons by sialidase.

Minami A, Ishii A, Shimba S, Kano T, Fujioka E, Sai S, Oshio N, Ishibashi S, Takahashi T, Kurebayashi Y, Kanazawa H, Yuki N, Otsubo T, Ikeda K, Suzuki T.

J Biochem. 2018 Apr 1;163(4):273-280. doi: 10.1093/jb/mvy003.

PMID:
29319803
4.

Acute Tetraparesis with Respiratory Failure after Steroid Administration in a Patient with a Dural Arteriovenous Fistula at the Craniocervical Junction.

Takahashi H, Ueshima T, Goto D, Kimura T, Yuki N, Inoue Y, Yoshioka A.

Intern Med. 2018 Feb 15;57(4):591-594. doi: 10.2169/internalmedicine.9115-17. Epub 2017 Dec 8.

5.

An Adult Case of Recurrent Guillain-Barré Syndrome with Anti-galactocerebroside Antibodies.

Takahashi H, Kimura T, Yuki N, Yoshioka A.

Intern Med. 2018 Feb 1;57(3):409-412. doi: 10.2169/internalmedicine.8941-17. Epub 2017 Nov 1.

6.

Overlap of acute mydriasis and acute pharyngeal weakness associated with anti-GQ1b antibodies.

Wakerley BR, Hamada S, Tashiro K, Moriwaka F, Yuki N.

Muscle Nerve. 2018 Jan;57(1):E94-E95. doi: 10.1002/mus.25767. Epub 2017 Aug 29. No abstract available.

PMID:
28802059
7.

Acute painful autoimmune neuropathy: A variant of Guillain-Barré syndrome.

Yuki N, Chan AC, Wong AHY, Inoue T, Yokai M, Kurihara T, Devaux JJ, Wilder-Smith E.

Muscle Nerve. 2018 Feb;57(2):320-324. doi: 10.1002/mus.25738. Epub 2017 Jul 24.

PMID:
28667708
8.

Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.

Mathey EK, Garg N, Park SB, Nguyen T, Baker S, Yuki N, Yiannikas C, Lin CS, Spies JM, Ghaoui R, Barnett MH, Vucic S, Pollard JD, Kiernan MC.

J Neuroimmunol. 2017 Aug 15;309:41-46. doi: 10.1016/j.jneuroim.2017.05.002. Epub 2017 May 13.

PMID:
28601286
9.

Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.

Delmont E, Manso C, Querol L, Cortese A, Berardinelli A, Lozza A, Belghazi M, Malissart P, Labauge P, Taieb G, Yuki N, Illa I, Attarian S, Devaux JJ.

Brain. 2017 Jul 1;140(7):1851-1858. doi: 10.1093/brain/awx124.

PMID:
28575198
10.

Memory B cells in Guillain-Barré syndrome.

Wang Q, Xing C, Hao Y, Shi Q, Qi Z, Lv Z, Song Y, Xu P, Feng X, Zhang L, Zhang Y, Wang Y, Yuki N.

J Neuroimmunol. 2017 Apr 15;305:1-4. doi: 10.1016/j.jneuroim.2017.01.004. Epub 2017 Jan 13.

PMID:
28284328
11.

IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barré syndrome.

Wang Y, Shi Q, Lv H, Hu M, Wang W, Wang Q, Qiao B, Zhang G, Lv Z, Kjellman C, Järnum S, Winstedt L, Zhang Y, Wen J, Hao Y, Yuki N.

Exp Neurol. 2017 May;291:134-140. doi: 10.1016/j.expneurol.2017.02.010. Epub 2017 Feb 16.

PMID:
28214515
12.

Brain Gangliosides in Alzheimer's Disease: Increased Expression of Cholinergic Neuron-Specific Gangliosides.

Fukami Y, Ariga T, Yamada M, Yuki N.

Curr Alzheimer Res. 2017;14(6):586-591. doi: 10.2174/1567205014666170117094038.

PMID:
28124591
13.

Electrodiagnosis of reversible conduction failure in Guillain-Barré syndrome.

Chan YC, Punzalan-Sotelo AM, Kannan TA, Shahrizaila N, Umapathi T, Goh EJH, Fukami Y, Wilder-Smith E, Yuki N.

Muscle Nerve. 2017 Nov;56(5):919-924. doi: 10.1002/mus.25577. Epub 2017 Apr 11.

PMID:
28093784
14.

Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases.

Pilch KS, Spaeth PJ, Yuki N, Wakerley BR.

Expert Rev Neurother. 2017 Jun;17(6):579-591. doi: 10.1080/14737175.2017.1282821. Epub 2017 Mar 6. Review.

PMID:
28092989
15.

Schwann cells are activated by ATP released from neurons in an in vitro cellular model of Miller Fisher syndrome.

Rodella U, Negro S, Scorzeto M, Bergamin E, Jalink K, Montecucco C, Yuki N, Rigoni M.

Dis Model Mech. 2017 May 1;10(5):597-603. doi: 10.1242/dmm.027870. Epub 2017 Jan 6.

16.

Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies.

Vallat JM, Yuki N, Sekiguchi K, Kokubun N, Oka N, Mathis S, Magy L, Sherman DL, Brophy PJ, Devaux JJ.

Neuromuscul Disord. 2017 Mar;27(3):290-293. doi: 10.1016/j.nmd.2016.10.008. Epub 2016 Oct 24.

17.

MicroRNA expression profiling in Guillain-Barré syndrome.

Lv Z, Shi Q, Huang W, Xing C, Hao Y, Feng X, Yang Y, Zhang A, Kong Q, Yuki N, Wang Y.

J Neuroimmunol. 2016 Dec 15;301:12-15. doi: 10.1016/j.jneuroim.2016.10.014. Epub 2016 Nov 4.

PMID:
27836180
18.

Membrane binding, endocytic trafficking and intracellular fate of high-affinity antibodies to gangliosides GD1a and GM1.

Ruggiero FM, Vilcaes AA, Yuki N, Daniotti JL.

Biochim Biophys Acta Biomembr. 2017 Jan;1859(1):80-93. doi: 10.1016/j.bbamem.2016.10.020. Epub 2016 Oct 30. No abstract available.

19.

Altered gene expression of glycosyltransferases and sialyltransferases and total amount of glycosphingolipids following herpes simplex virus infection.

Miyaji K, Furukawa JI, Suzuki Y, Yamamoto N, Shinohara Y, Yuki N.

Carbohydr Res. 2016 Nov 3;434:37-43. doi: 10.1016/j.carres.2016.08.004. Epub 2016 Aug 18.

PMID:
27588895
20.

Clinical Reasoning: Temporal profile of inflammatory neuropathies: Beginning to make sense of the uncertainties.

Chandra B, Vijayan J, Yuki N, Therimadasamy A, Wilder-Smith E.

Neurology. 2016 Oct 18;87(16):e182-e188. No abstract available.

PMID:
27754913
21.

An animal model of Miller Fisher syndrome: Mitochondrial hydrogen peroxide is produced by the autoimmune attack of nerve terminals and activates Schwann cells.

Rodella U, Scorzeto M, Duregotti E, Negro S, Dickinson BC, Chang CJ, Yuki N, Rigoni M, Montecucco C.

Neurobiol Dis. 2016 Dec;96:95-104. doi: 10.1016/j.nbd.2016.09.005. Epub 2016 Sep 3.

22.

Reply.

Kimachi T, Yuki N, Kokubun N, Yamaguchi S, Wakerley BR.

Muscle Nerve. 2017 Mar;55(3):446-447. doi: 10.1002/mus.25424. Epub 2016 Nov 16. No abstract available.

PMID:
27699798
23.

Clinical classification of 103 Japanese patients with Guillain-Barré syndrome.

Wakerley BR, Kokubun N, Funakoshi K, Nagashima T, Hirata K, Yuki N.

J Neurol Sci. 2016 Oct 15;369:43-47. doi: 10.1016/j.jns.2016.08.002. Epub 2016 Aug 2.

PMID:
27653863
24.

A case of a 17-year-old male with neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy presenting with tremor and ataxia.

Itaya K, Inoue M, Iizuka N, Shimizu Y, Yuki N, Ichikawa H.

Rinsho Shinkeigaku. 2016 Sep 29;56(9):633-6. doi: 10.5692/clinicalneurol.cn-000853. Epub 2016 Aug 31. Japanese.

PMID:
27580761
25.

Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies.

Sudo M, Miyaji K, Späth PJ, Morita-Matsumoto K, Yamaguchi Y, Yuki N.

Int Immunopharmacol. 2016 Nov;40:11-15. doi: 10.1016/j.intimp.2016.08.019. Epub 2016 Aug 24.

PMID:
27567246
26.

Paraparetic Guillain-Barré syndrome: Nondemyelinating reversible conduction failure restricted to the lower limbs.

Kimachi T, Yuki N, Kokubun N, Yamaguchi S, Wakerley BR.

Muscle Nerve. 2017 Feb;55(2):281-285. doi: 10.1002/mus.25242. Epub 2016 Nov 28.

PMID:
27397635
27.

Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.

Notturno F, Kokubun N, Sekiguki Y, Nagashima T, De Lauretis A, Yuki N, Kuwabara S, Uncini A.

J Neurol Sci. 2016 Jun 15;365:132-6. doi: 10.1016/j.jns.2016.02.053. Epub 2016 Feb 23.

PMID:
27206890
28.

Recurrent Guillain-Barré syndrome, Miller Fisher syndrome and Bickerstaff brainstem encephalitis.

Ishii J, Yuki N, Kawamoto M, Yoshimura H, Kusunoki S, Kohara N.

J Neurol Sci. 2016 May 15;364:59-64. doi: 10.1016/j.jns.2016.03.008. Epub 2016 Mar 3.

PMID:
27084218
29.

How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis?

Sekiguchi Y, Mori M, Misawa S, Sawai S, Yuki N, Beppu M, Kuwabara S.

Eur J Neurol. 2016 Jun;23(6):1058-63. doi: 10.1111/ene.12983. Epub 2016 Mar 11.

PMID:
26969889
30.

Protective Effect of a Synbiotic against Multidrug-Resistant Acinetobacter baumannii in a Murine Infection Model.

Asahara T, Takahashi A, Yuki N, Kaji R, Takahashi T, Nomoto K.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3041-50. doi: 10.1128/AAC.02928-15. Print 2016 May.

31.

Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies.

Hacohen Y, Nishimoto Y, Fukami Y, Lang B, Waters P, Lim MJ, Yuki N, Vincent A.

Dev Med Child Neurol. 2016 Aug;58(8):836-41. doi: 10.1111/dmcn.13090. Epub 2016 Feb 25.

32.

Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.

Miyaji K, Paul F, Shahrizaila N, Umapathi T, Yuki N.

J Neuroimmunol. 2016 Feb 15;291:78-81. doi: 10.1016/j.jneuroim.2015.12.012. Epub 2015 Dec 30.

PMID:
26857499
33.

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

Devaux JJ, Miura Y, Fukami Y, Inoue T, Manso C, Belghazi M, Sekiguchi K, Kokubun N, Ichikawa H, Wong AH, Yuki N.

Neurology. 2016 Mar 1;86(9):800-7. doi: 10.1212/WNL.0000000000002418. Epub 2016 Feb 3.

34.

Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome.

Lardone RD, Yuki N, Irazoqui FJ, Nores GA.

Sci Rep. 2016 Jan 28;6:19901. doi: 10.1038/srep19901.

35.

Hemiparetic Guillain-Barré syndrome.

Kim JE, Yuki N.

J Neurol Sci. 2016 Feb 15;361:131-2. doi: 10.1016/j.jns.2015.12.030. Epub 2015 Dec 21. No abstract available.

PMID:
26810530
36.

Serial electrophysiological studies in a Guillain-Barré subtype with bilateral facial neuropathy.

Chan YC, Therimadasamy AK, Sainuddin NM, Wilder-Smith E, Yuki N.

Clin Neurophysiol. 2016 Feb;127(2):1694-1699. doi: 10.1016/j.clinph.2015.11.011. Epub 2015 Nov 19.

PMID:
26652112
37.

[The mechanism of autoimmune disease by glycotope mimicry].

Yuki N.

Seikagaku. 2015 Jun;87(3):337-41. Review. Japanese. No abstract available.

PMID:
26571600
38.

[Molecular Mimicry and Guillain-Barré Syndrome].

Yuki N.

Brain Nerve. 2015 Nov;67(11):1341-6. doi: 10.11477/mf.1416200304. Review. Japanese.

PMID:
26560949
39.

Intestinal Microbiota Profiles of Healthy Pre-School and School-Age Children and Effects of Probiotic Supplementation.

Wang C, Nagata S, Asahara T, Yuki N, Matsuda K, Tsuji H, Takahashi T, Nomoto K, Yamashiro Y.

Ann Nutr Metab. 2015;67(4):257-66. doi: 10.1159/000441066. Epub 2015 Oct 24.

PMID:
26496372
40.

Treatment of pressure ulcers in patients with declining renal function using arginine, glutamine and ß-hydroxy-ß-methylbutyrate.

Ogura Y, Yuki N, Sukegane A, Nishi T, Miyake Y, Sato H, Miyamoto C, Mihara C.

J Wound Care. 2015 Oct;24(10):478-82. doi: 10.12968/jowc.2015.24.10.478.

PMID:
26488739
41.

Acute bulbar, neck and limb weakness with monospecific anti-GT1a antibody: A rare localized subtype of Guillain-Barré syndrome.

Garg N, Yuki N, Park SB, Barnett MH, Kiernan MC.

Muscle Nerve. 2016 Jan;53(1):143-6. doi: 10.1002/mus.24935. Epub 2015 Nov 23.

PMID:
26452439
42.

Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome.

Shinchi H, Yuki N, Ishida H, Hirata K, Wakao M, Suda Y.

PLoS One. 2015 Sep 17;10(9):e0137966. doi: 10.1371/journal.pone.0137966. eCollection 2015.

43.

Polyneuritis cranialis--subtype of Guillain-Barré syndrome?

Wakerley BR, Yuki N.

Nat Rev Neurol. 2015 Nov;11(11):664. doi: 10.1038/nrneurol.2015.115. Epub 2015 Sep 15. No abstract available.

PMID:
26369515
44.

Action mechanism of corticosteroids to aggravate Guillain-Barré syndrome.

Wang YZ, Lv H, Shi QG, Fan XT, Li L, Yi Wong AH, Hao YL, Si CP, Li CL, Yuki N.

Sci Rep. 2015 Sep 10;5:13931. doi: 10.1038/srep13931.

45.

Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias.

Wakerley BR, Yuki N.

Muscle Nerve. 2015 Dec;52(6):927-32. doi: 10.1002/mus.24887. Epub 2015 Sep 12. Review.

PMID:
26315943
46.

Delayed facial palsy in Miller Fisher syndrome.

Tan CY, Yuki N, Shahrizaila N.

J Neurol Sci. 2015 Nov 15;358(1-2):409-12. doi: 10.1016/j.jns.2015.08.009. Epub 2015 Aug 7.

PMID:
26277343
47.

Autoimmune inflammatory neuropathies: updates in pathogenesis, diagnosis, and treatment.

Wong AH, Yuki N.

Curr Opin Neurol. 2015 Oct;28(5):468-73. doi: 10.1097/WCO.0000000000000242. Review.

PMID:
26263472
48.

Serial peripheral nerve ultrasound in Guillain-Barré syndrome.

Razali SNO, Arumugam T, Yuki N, Rozalli FI, Goh KJ, Shahrizaila N.

Clin Neurophysiol. 2016 Feb;127(2):1652-1656. doi: 10.1016/j.clinph.2015.06.030. Epub 2015 Jul 17.

PMID:
26228791
49.

Association of Anti-GT1a Antibodies with an Outbreak of Guillain-Barré Syndrome and Analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain.

Zhang M, Gilbert M, Yuki N, Cao F, Li J, Liu H, Li Q, Meng F, Zhang J.

PLoS One. 2015 Jul 21;10(7):e0131730. doi: 10.1371/journal.pone.0131730. eCollection 2015.

50.

Streptococcal IdeS: therapeutic potential for Guillain-Barré syndrome.

Takahashi R, Yuki N.

Sci Rep. 2015 Jul 21;5:10809. doi: 10.1038/srep10809.

Supplemental Content

Support Center